International Patent: DEUTERATED 1,2,4-TRIAZOLE APELIN RECEPTOR AGONIST DRUG AND USE

GENEVA, July 1 -- YAOKANG ZHONGTUO (BEIJING) PHARMACEUTICAL TECHNOLOGY CO., LTD filed a patent application (CN2024/138343) for “DEUTERATED 1,2,4-TRIAZOLE APELIN RECEPTOR AGONIST DRUG AND USE”. With publication no. WO/2026/123230, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 401/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....